Form 8-K - Current report:
SEC Accession No. 0001193125-25-036898
Filing Date
2025-02-26
Accepted
2025-02-26 17:11:09
Documents
13
Period of Report
2025-02-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d919630d8k.htm   iXBRL 8-K 26727
  Complete submission text file 0001193125-25-036898.txt   145573

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mgnx-20250225.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgnx-20250225_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgnx-20250225_pre.xml EX-101.PRE 10812
16 EXTRACTED XBRL INSTANCE DOCUMENT d919630d8k_htm.xml XML 3535
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 25671336
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)